🌞The day has arrived!🌞🌞

🚨Today is the Respiratory Infections: Update on Managing Bronchiectasis and NTM Pulmonary Disease seminar, taking place at 12pm.

It's not too late to sign up, whether attending in-person or online!👏

Register here: bit.ly/4lmcsab

#CRERESPOND #UQCCR #RespiratoryInfections

👏We are honoured to have Dr Jefman Efendi, a Clinical Pharmacology Physician from Ubaya Hospital in Indonesia, presenting on 'Exploring MIPD Opportunities for Clinical Practice in Indonesia'.

Register here: bit.ly/3GtrIUb

#UQCCR #PrecisionDosing #Worldwide #CRERESPOND #Drugs #MIPD #Optimisation

Introducing our first speaker of CRE RESPOND's Worldwide Precision Dosing seminar on 7 August 2025, Mr Tony Lai!🤩

‼️We are honoured to have Mr Lai presenting with us on 'Antifungal Dosing in Kids'🧒👧

Find out more and register here: bit.ly/3GtrIUb

#UQCCR #Drugs #Therapy #Antifungal #Dosing #Kids

On 7 August 2025, we will be hosting our Worldwide Precision Dosing seminar for the fifth year!💉

📢Chaired by Dr Amy Legg, a clinical pharmacist at RBWH, this event explores individualised drug therapy.

To find out more about this event and register: bit.ly/3GtrIUb

@leggwamy.bsky.social
#UQCCR

Welcome to Day 2 of CRE RESPOND's Population Pharmacokinetics Workshop!🥳

👏Day 1 was a huge success and Day 2 is following in its footsteps. Today's session is all about Model Building and Validation!

Check out our site for information on future events: bit.ly/3espmH4

#PopPK #Workshop #UQCCR

🎉It's Day 1 of our 3-Day Population Pharmacokinetics Workshop!🎉

We've got a full house over at UQ Brisbane City - thank you to everyone who has registered and shown interest in this educational event.

Big thank you to CRE RESPOND's Patty Mitre for her amazing work!♥️

#UQCCR #CRERESPOND #PopPK

🎉 Exciting news! Our paper "ROS1 IHC as a potential predictive biomarker in breast cancer" has been chosen as the cover feature for this issue of @Histo_Journal ! 🧬💥

To read our paper ➡️ doi.org/10.1111/his....

#BreastCancer #Pathology #Histopathology #UQCCR

Did you know, CRE RESPOND has a quarterly newsletter to keep our subscribers informed on our amazing researchers and their current projects, as well as on our events and visitors?🤩

Now you never have to miss out on an update!👏

Subscribe now: bit.ly/4enYORH

#UQCCR #newsletter #antimicrobial

Brisbane Breast Bank - Lobular breast cancer research The Brisbane Breast Bank is a repository for donated breast cancer samples. The researchers in our team study a range of different types of breast cancers, including lobular breast cancer.

Lobular #breastcancer is under-recognised & under-researched — we're working to change that.

Support our #research at UQ & the Brisbane Breast Bank to improve detection & treatment💗

🔗 www.justgiving.com/campaign/bri...

#LobularBreastCancer #ILC #WomensHealth #UQCCR

🎤A/Prof @amymccart.bsky.social officially opened the Herston Breast Cancer Research Network at #UQCCR
An exciting step forward in strengthening collaboration across research, clinical care, & innovation in #breastcancer💗🧬#HerstonResearch #Collaboration #TranslationalResearch

🚨Check out the highlights from the Brisbane Transplant Infectious Diseases meeting 2025!🚨

We can't wait for BTID 2026👏

📢Don't forget to check out the recordings of the amazing presentations on our YouTube: bit.ly/3rxrFeP

#UQCCR #CRERespond #highlights #BTID2025 #reel #behindthescenes

cre.respond The Centre for Research Excellence RESPOND, The University of Queensland (UQ) aims to reduce antimicrobial resistance through optimised dosing. Subscribe to our page for updates and education semina...

The recordings for the Brisbane Transplant Infectious Diseases meeting 2025 are officially live!🤩

💊Head over to our YouTube to catch up on anything you may have missed, or to give yourself a refresh on what was discussed: bit.ly/3rxrFeP

#BTID2025 #infections #disease #transplant #UQCCR #CRERespond

✨Hello and welcome to the official CRE Respond page!✨

CRE RESPOND aims to reduce the burden of antimicrobial resistance through optimal personalised dosing. 💊

🚨Follow us to stay up to date with our educational events and the latest goings-on in the world of anti-microbial optimisation!

#uqccr

🍎Breast cancer... and apples?🍏@amymccart.bsky.social nailed her @pintofscienceAU talk with the perfect mix of science & analogies — a full house at Easy Times! Huge thanks to @MehershadW for hosting such a fun and insightful night! 👏🧠💥 #Pint2025 #UQCCR

ROS1 immunohistochemistry as a potential predictive biomarker for ROS1-targeted therapy in breast cancer: impact of antibody clone selection - PubMed Assessment of ROS1 status in breast cancer appears to be highly antibody clone-dependent. ROS1 antibody clone selection will be an important consideration in the design of clinical trials investigatin...

🚨Just in from our lab!

The🗝️ to efficiently implementing targeted therapies is a robust #biomarker and our work shows this is tricky for ROS1 in #breastcancer ⤵️

📖 pubmed.ncbi.nlm.nih.gov/40356444/ @histo-journal.bsky.social

#BreastCancer #Pathology #Biomarkers #UQCCR

Kicking off DNA extraction for the ctDNA lobular breast cancer project — part of Tivya's PhD! Can’t wait to see what secrets these tumours are hiding…

#LabLife #LobularBreastCancer #ctDNA #PhDLife #TeamScience #UQCCR

Worldwide Precision Dosing Seminar CRE RESPOND's fourth Annual Worldwide Precision Dosing seminar was held on Tuesday 10 September.  Our panel of expert clinicians and clinical educators, from America, Europe and Australia, covered whe...

Just in case you missed it Dr Emily Heil and Dr Julie Ann Justo with the greatest overview of aminoglycoside dosing for #UQCCR earlier this year! All the recordings here cre-respond.centre.uq.edu.au/event/sessio...

#uqccr #uq represent! Prof Salomon wowing the crowd again #multiomics2024 #evs#extracellularvesicles #ovariancancer